https://bioutah.org/canyon-labs-invests-in-commercial-leadership-to-give-medical-device-manufacturers-direct-access-to-expertise/2026-07-30T18:19:10ZBioUtahenCanyon Labs Invests in Commercial Leadership to Give Medical Device Manufacturers Direct Access to Expertise2026-07-30T18:19:10ZBloghttps://bioutah.org/sintx-technologies-engages-veteran-medtech-executive-chris-lyons-and-southern-metrics-to-establish-strategic-opportunity-management-program/2026-07-30T18:17:11ZBioUtahenSINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program2026-07-30T18:17:11ZBloghttps://bioutah.org/cancervax-named-a-top-preclinical-biotech-company-of-2026-by-life-sciences-review/2026-07-30T18:15:16ZBioUtahenCancerVax Named a Top Preclinical Biotech Company of 2026 by Life Sciences Review2026-07-30T18:15:16ZBloghttps://bioutah.org/biomerics-appoints-medical-device-industry-veteran-lokram-natarajan-as-senior-vice-president-of-quality-to-support-continued-global-growth/2026-07-30T18:14:04ZBioUtahenBiomerics Appoints Medical Device Industry Veteran Lokram Natarajan as Senior Vice President of Quality to Support Continued Global Growth2026-07-30T18:14:04ZBloghttps://bioutah.org/co-diagnostics-joint-venture-cosara-provides-ebola-test-kits-for-analytical-studies/2026-07-30T18:12:52ZBioUtahenCo-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies2026-07-30T18:12:52ZBloghttps://bioutah.org/biomarin-and-n-lorem-foundation-enter-early-research-collaboration-to-develop-potential-first-in-disease-medicine-for-newly-identified-renu-syndrome/2026-07-30T18:11:34ZBioUtahenBioMarin and n-Lorem Foundation Enter Early Research Collaboration to Develop Potential First-in-Disease Medicine for Newly Identified ReNU Syndrome2026-07-30T18:11:34ZBlog